Gilead Sciences
GILD
#78
Rank
NZ$377.35 B
Marketcap
NZ$304.23
Share price
-0.06%
Change (1 day)
34.90%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: NZ$377.35 Billion

As of November 2026 Gilead Sciences has a market cap of NZ$377.35 Billion. This makes Gilead Sciences the world's 78th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$377.35 B41.24%
2025NZ$267.16 B28.47%
2024NZ$207.96 B30.29%
2023NZ$159.61 B-5.88%
2022NZ$169.59 B27.22%
2021NZ$133.30 B31.71%
2020NZ$101.21 B-17.14%
2019NZ$122.14 B2.18%
2018NZ$119.54 B-9.27%
2017NZ$131.76 B-3.25%
2016NZ$136.19 B-35.22%
2015NZ$210.24 B16.58%
2014NZ$180.33 B28.6%
2013NZ$140.22 B106.77%
2012NZ$67.81 B72.16%
2011NZ$39.39 B4.56%
2010NZ$37.67 B-29.72%
2009NZ$53.60 B-33.2%
2008NZ$80.23 B43.81%
2007NZ$55.79 B31.28%
2006NZ$42.49 B20.19%
2005NZ$35.35 B60.66%
2004NZ$22.00 B15.11%
2003NZ$19.11 B48.94%
2002NZ$12.83 B-15.97%
2001NZ$15.27 B73.12%
2000NZ$8.82 B93.21%
1999NZ$4.56 B90.85%
1998NZ$2.39 B20.82%
1997NZ$1.98 B94.62%
1996NZ$1.01 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Gilead Sciences was reported to be:

NZ$377.35 Billion
by Nasdaq info icon info icon
NZ$377.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.190 T 215.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$285.48 B-24.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$924.77 B 145.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.193 T 481.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$430.75 B 14.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$67.44 B-82.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$53.29 B-85.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$238.69 B-36.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$602.60 B 59.69%๐Ÿ‡บ๐Ÿ‡ธ USA